WALTHAM, Mass.--(BUSINESS WIRE)--Nov 24, 2025-- Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of €2.1 billion aggregate principal amount (the “Offering”) of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific (Finance I) B.V., its indirect, wholly-owned finance subsidiary: €1,000,000,000 aggregate principal amount of its floating rate senior notes due 2027 (the “floating rate notes”) at the issue price of 100.000% of their principal amount; and €1,100,000,000 aggregate principal amount of its 3.628% senior notes due 2035 (the “fixed rate notes,” and together with the floating rate notes, the “notes”) at the issue price of 100.000% of their principal amount. The Offering is expected to close on or about December 1, 2025, subject to the satisfaction of customary closing conditions. The notes will be fully and unconditionally guaranteed by Thermo Fisher.